Insys Therapeutics News

Insys to Pay $225 Million to Settle Opioid-Sales Probe

Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle U.S. claims that the drug maker illegally sold opioid-based painkillers. Under terms of the deal, Insys …

Insys Agrees to $225 Million, 5-Year Settlement of U.S. Opioid Sales Claims

Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle U.S. claims that the drug maker illegally sold opioid-based painkillers. Under terms of the deal, Insys …

McKesson Opioid Deal in West Virginia May Spur More Accords

McKesson Corp.’s settlement of an opioid lawsuit with West Virginia — the state with the highest U.S. rate of drug-overdose deaths — may encourage other states to seek quick cash to cope with the rising societal costs of addiction. West …

Opioid Evangelist Switches Sides in Case Alleging Pharma Abuse

A doctor who was an early evangelist for increased use of highly addictive opioids like OxyContin to treat chronic pain — and who was paid to promote the idea — has switched sides and now says drug makers helped to …